Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)

China · Delayed Price · Currency is CNY

30.50

-0.57 (-1.83%)

At close: May 12, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Business		426.01M	483.10M	548.95M	511.66M	466.86M
Pharmaceutical Business Growth		-11.82%	-12.00%	7.29%	9.60%	3.18%
Unallocated Other Business		3.46M	6.19M	19.26M	10.03M	9.98M
Unallocated Other Business Growth		-44.10%	-67.86%	92.00%	0.47%	-
Total		429.47M	489.29M	568.21M	521.70M	476.85M
Total Growth		-12.23%	-13.89%	8.92%	9.40%	5.38%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China		218.24M	181.40M	197.57M	165.98M	118.39M
China Growth		20.31%	-8.19%	19.03%	40.20%	-5.05%
Abroad		211.23M	307.89M	370.64M	355.71M	358.46M
Abroad Growth		-31.39%	-16.93%	4.20%	-0.77%	11.63%
Total		429.47M	489.29M	568.21M	521.70M	476.85M
Total Growth		-12.23%	-13.89%	8.92%	9.40%	6.97%

Source: S&P Global Market Intelligence.